PH-responsive polyethylene glycol-anticarcinogen conjugate, and synthetic method and application thereof

一种聚乙二醇、响应性的技术,应用在生物医药领域,能够解决人体正常细胞损伤、限制临床效果、稳定性差等问题

Inactive Publication Date: 2012-05-30
INST OF CHEM CHINESE ACAD OF SCI
View PDF0 Cites 34 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, less than 10% of tumor patients can undergo preoperative chemotherapy and complete resection after radiotherapy, although about 90% of patients can receive radiotherapy, including radiofrequency or alcohol ablation, and administration of doxorubicin, 5-fluorouracil, etc. for systemic or arterial infusion. Injection, embolization and other chemotherapy treatments, these methods or drugs can indeed have a certain inhibitory or killing effect on tumor tissues or cells. However, when using traditional preparations to treat tumors, the drug-loading system cannot distinguish between normal tissues and tumors. Tissues, normal cells and tumor cells, so that the drug kills the cancer cells, but also brings serious damage to the normal cells of the human body. This is a serious problem that currently limits the dosage of drugs, therapeutic effects and quality of life of patients (Ann. Surg., 1999, 229, 790-800)
On the other hand, many new cancer drugs under development have good killing / inhibitory effects on tumor cells in vitro experiments, but most of the drugs have complex structures, poor stability, and low solubility in water (about 40% of the drugs are non-water-soluble). properties) (Drug Discovery, 2003, 2, 337 and references therein), new preparation systems are required to adapt to it, otherwise their clinical effects will be greatly limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Example 1 Synthesis of a pH-responsive polyethylene glycol-anticancer drug bond based on methoxypolyethylene glycol benzaldehyde monoester

[0067] The synthetic pathway of the reaction is as follows:

[0068]

[0069]

[0070] (1) Add 4g (0.002mol) monomethoxypolyethylene glycol, 2.4g (0.016mol) p-formylbenzoic acid, 0.1222g (0.001mol) 4-dimethylaminopyridine (DMAP) to 100ml In the round bottom flask, add 60ml of dry dichloromethane to mix the reactants evenly. In a water bath at 37°C under stirring, 10 ml of a solution of 3.3 g (0.016 mol) N, N'-dicyclohexylcarbodiimide (DCC) in dichloromethane was added dropwise to a round bottom flask to remove the reaction water produced in. After stirring at constant temperature for 24 hours, the reaction liquid was filtered to remove the reaction by-product N, N'-dicyclohexyl urea (DCU); Washing with glacial ether three times; after vacuum drying to remove the solvent, washing with water to remove excess DCC, and freeze-dr...

Embodiment 2

[0072] Example 2 Synthesis of a pH-responsive targeted polyethylene glycol-anticancer drug conjugate based on folic acid-terminated polyethylene glycol benzaldehyde

[0073] (1) Mix 3.4g (0.001mol) polyethylene glycol with one-terminal amino group and one-terminal folic acid group and 0.99g (0.004mol, the molar ratio of one-terminal amino group and one-terminal folic acid group polyethylene glycol is 1:4) N-succinyl The imino-p-formyl benzoate (SFB) was dissolved in 60 ml of dry dichloromethane, and reacted under stirring for 24 hours in a water bath at 50°C. After the reaction, the reaction solution was filtered to remove unreacted SFB; the filtrate was concentrated and then recrystallized with isopropanol, and the obtained crude product was washed three times with isopropanol and glacial ether, dried in vacuo to remove the solvent, and obtained a light yellow Powdered product - folate-terminated polyethylene glycol benzaldehyde amide.

[0074] (2) Take by weighing 77.8mg (0...

Embodiment 3

[0075] Example 3 Synthesis of a pH-responsive polyethylene glycol-anticancer drug conjugate based on benzaldehyde-terminated polyethylene glycol

[0076] (1) 4.6g (0.001mol) of polyethylene glycol with a molecular weight of 4600, 1.236g (0.008mol) of p-formylbenzyl chloride were dissolved in 60ml of dry chloroform, and 0.6g of K 2 CO 3 , after reflux at 80°C for 8 hours, filter the reaction solution, concentrate the filtrate and recrystallize with isopropanol, and wash the crude product three times with isopropanol and glacial ether successively; after vacuum drying, a white powder is obtained The product is benzaldehyde-terminated polyethylene glycol (polyethylene glycol with benzaldehyde groups at both ends linked by ether linkages).

[0077] (2) Take by weighing 214mg (0.4mmol) demethoxydaunorubicin, 242mg (0.05mmol, with the molar ratio of demethoxydaunorubicin 1:8) the terminal benzaldehyde synthesized in step (1) Polyethylene glycol was dissolved in 100 ml of dry ethan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pH-responsive polyethylene glycol-anticarcinogen conjugate, and a synthetic method and application thereof. After anticarcinogen molecules and polyethylene glycol are covalently linked through pH-sensitive phenylimide linkage, the conjugate is formed, wherein, anticarcinogen can be doxorubicin, epirubicin, daunorubicin, demethoxydaunorubicin or hydrochlorides of the above-mentioned anticarcinogens. The phenylimide linkage is stable under the condition of a normal physiological pH value but undergoes hydrolysis under the condition of a slightly acidic pH value, e.g., a solid tumor cell external pH value and a cell endosome and lysosome pH value; that is, the phenylimide linkage is sensitive to changes of pH values in a range of 7.4 to 4.5 or to below 4.5. The polyethylene glycol-anticarcinogen conjugate has amphiphilic nature and can form nanometer-scale micelle in a saline solution through self-assembly; the micelle can be used as a drug carrier to carry hydrophobic drugs and form a nanometer micelle preparation cladded with drugs, thereby realizing synergy therapy of a plurality of drugs.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a pH-responsive polyethylene glycol-anticancer drug bond based on a phenylimine bond and a synthesis method thereof, and the polyethylene glycol-anticancer drug The application of the bond as a drug carrier. Background technique [0002] Cancer seriously endangers human life and health. According to the statistics of the World Health Organization, 7.6 million people died of cancer in the world in 2005, and it is estimated that the number will reach 9 million in 2015 and 11.5 million in 2030. Cancer has been listed as the "No. 2 killer" (after cardiovascular disease) facing mankind (China Cancer, 2009, 18, 88-89). Due to the difficulty of early detection, its treatment has always been a difficult point in the medical field. At present, less than 10% of tumor patients can undergo preoperative chemotherapy and complete resection after radiotherapy, although about ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/48A61K31/704A61K31/4745A61K31/337A61K31/519A61K31/12A61K31/4375A61K31/216A61P35/00A61K47/34
Inventor 杨振忠朱丽君屈小中刘继广张成亮李焦丽王倩
Owner INST OF CHEM CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products